Clinical Trial Update: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating whether intravenous glutathione can prevent paclitaxel/carboplatin-induced peripheral neuropathy in patients with ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Glutathione (glutathione)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Chemotherapeutic Agent Toxicity, Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2017-02-23